Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation

J Pediatr Hematol Oncol. 2022 Jul 1;44(5):268-270. doi: 10.1097/MPH.0000000000002437. Epub 2022 Mar 1.

Abstract

Donor cell leukemia is a rare complication following hematopoietic stem cell transplant (HSCT). There are currently few reports in children and only rare, reported cases of donor-derived myelodysplastic syndrome/acute myeloid leukemia in patients with an underlying germline GATA2 mutation. Most reported cases are myeloid in origin and occur following related HSCT. We present a 3-year-old female who developed a donor-derived B-cell acute lymphoblastic leukemia 2 years post unrelated HSCT for GATA2 germline mutation.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Child, Preschool
  • Female
  • GATA2 Transcription Factor / genetics
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Leukemia, Myeloid, Acute* / genetics
  • Mutation
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy
  • Unrelated Donors

Substances

  • GATA2 Transcription Factor
  • GATA2 protein, human